Amryt Pharma Plc (AMYT) ORD GBP0.06
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
167.50p
168.74p
241.00p
£300.47 million
167.50p
165.75p
151.00p
n/a
0.00p (0.00%) Previous:
0.00p
2,454
n/a
1,500
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2020 | 31/12/2019 |
|---|---|---|
| Revenue ($m) | 182.61 | 58.12 |
| Profit before tax ($m) | (105.86) | (63.49) |
| Adjusted EPS (¢): | (66.00) | (83.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
FDA grants Amryt's Oleogel-S10 priority review status
3 June 2021 11:26
-
Amryt completes rolling FDA submission for Oleogel-S10
31 March 2021 11:50
-
Amryt releases data from Italy lomitapide study
30 March 2021 12:11
-
Amryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of C
15 June 2021 11:45
-
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
7 June 2021 12:00
-
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
3 June 2021 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.